Product news

Share this article:
Mylan has received final FDA approval for its fluoxetine capsules—10 mg and 20 mg—a generic form of Lilly's antidepressant, Sarafem Pulvules Capsules. Sarafem Pulvules Capsules brought in roughly $19.2 million for the 12 months ending Sept. 30, according to IMS Health. 
 
Two Johnson & Johnson subsidiaries (Janssen and ALZA) were found liable in the death of a Cicero, IL, woman, who died while using a Duragesic patch. A Chicago court awarded Janice DiCosolo's family with $16.5 million. DiCosolo's family argued that the defendants were aware of the patch's defect, which caused fentanyl to leak in large enough amounts to be fatal. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.